Español
PrintEmail
Decrease (-) Restore Default Increase (+)
In This Section Texas Health Research & Education Institute

Clinical Trials

Disease or Condition   Breast Cancer
Title   A PHASE III DOUBLE BLIND STUDY OF LETROZOLE VERSUS PLACEBO IN WOMEN WITH PRIMARY BREAST CANCER
Description   STUDY OF LETROZOLE VERSUS PLACEBO IN WOMEN WITH PRIMARY BREAST CANCER COMPLETING FIVE OR MORE YEARS OF ADJUVANT TAMOXIFEN.
IRB Number   Pro103
Inclusion/Notes   INCLUSION:
  • Post-menopausal women with receptor positive or unknown receptor status breast cancer who have ompleted at least 5 years of adjuvant therapy with tamoxifen and are free of disease will be studied.

EXCLUSION:
  • This phase III study will be available to all patients meeting the eligibility criteria regardless of race or thnic origin.

Status   Active - not Recruiting
Location   Texas Health Presbyterian Hospital Dallas
Principal Name    James Fredric Strauss MD
Contact Name   Lauren Braunfeld
Phone   (214) 345-2619

Online Tools

Locations

Helpful Info

Links